Monocyte emigration from bone marrow during bacterial infection requires signals mediated by chemokine receptor CCR2

Nature Immunology

Volumn 7, Issue 3, 2006, Pages 311-317

  Serbina, Natalya V ^a   Pamer, Eric G ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR; LY 6C ANTIGEN, MOUSE; LY ANTIGEN; LY-6C ANTIGEN, MOUSE; MONOCYTE CHEMOATTRACTANT PROTEIN 1 RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL INFECTION; BIOACCUMULATION; BONE MARROW; CELL ACTIVATION; CIRCULATION; CONTROLLED STUDY; FREQUENCY ANALYSIS; LEUKOCYTE MIGRATION; LISTERIA MONOCYTOGENES; MONOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; ANIMAL; BONE MARROW CELL; CELL DIFFERENTIATION; CYTOLOGY; FLOW CYTOMETRY; IMMUNOLOGY; METABOLISM; NEUTROPHIL CHEMOTAXIS;

ANIMALS; ANTIGENS, LY; BACTERIAL INFECTIONS; BONE MARROW CELLS; CELL DIFFERENTIATION; CHEMOTAXIS, LEUKOCYTE; FLOW CYTOMETRY; MICE; MONOCYTES; RECEPTORS, CHEMOKINE;

EID: 33645902493     PISSN: 15292908     EISSN: 15292916     Source Type: Journal    
DOI: 10.1038/ni1309     Document Type: Article

References (50)

1. Cyster, J.G. Lymphoid organ development and cell migration. Immunol. Rev. 195, 5-14 (2003).
2. Lapidot, T. & Petit, I. Current understanding of stem cell mobilization: the roles of chemokines, proteolytic enzymes, adhesion molecules, cytokines, and stromal cells. Exp. Hematol. 30, 973-981 (2002).
3. Nagasawa, T., Kikutani, H. & Kishimoto, T. Molecular cloning and structure of a pre-B-cell growth-stimulating factor. Proc. Natl. Acad. Sci. USA 91, 2305-2309 (1994).
4. Bleul, C.C., Fuhlbrigge, R.C., Casasnovas, J.M., Aiuti, A. & Springer, T.A. A highly efficacious lymphocyte chemoattractant, stromal cell-derived factor 1 (SDF-1). J. Exp. Med. 184, 1101-1109 (1996).
5. + cells: Role in transendothelial/stromal migration and engraftment of NOD/SCID mice. Blood 95, 3289-3296 (2000).
6. Shen, H. et al. CXCR-4 desensitization is associated with tissue localization of hemopoietic progenitor cells. J. Immunol. 166, 5027-5033 (2001).
7. Hidalgo, A. et al. Chemokine stromal cell-derived factor-1α modulates VLA-4 integrin-dependent adhesion to fibronectin and VCAM-1 on bone marrow hematopoietic progenitor cells. Exp. Hematol. 29, 345-355 (2001).
8. Hernandez, P.A. et al. Mutations in the chemokine receptor gene CXCR4 are associated with WHIM syndrome, a combined immunodeficiency disease. Nat. Genet. 34, 70-74 (2003).
9. Gorlin, R.J. et al. WHIM syndrome, an autosomal dominant disorder: clinical, hematological, and molecular studies. Am. J. Med. Genet. 91, 368-376 (2000).
10. Geissmann, F., Jung, S. & Littman, D.R. Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity 19, 71-82 (2003).
11. Luther, S.A. & Cyster, J.G. Chemokines as regulators of T cell differentiation. Nat. Immunol. 2, 102-107 (2001).
12. Kurihara, T., Warr, G., Loy, J. & Bravo, R. Defects in macrophage recruitment and host defense in mice lacking the CCR2 chemokine receptor. J. Exp. Med. 186, 1757-1762 (1997).
13. Sato, N. et al. CC chemokine receptor (CCR)2 is required for langerhans cell migration and localization of T helper cell type 1 (Th1)-inducing dendritic cells: Absence of CCR2 shifts the Leishmania major-resistant phenotype to a susceptible state dominated by Th2 cytokines, B cell outgrowth, and sustained neutrophilic inflammation. J. Exp. Med. 192, 205-218 (2000).
14. Peters, W. et al. Chemokine receptor 2 serves an early and essential role in resistance to Mycobacterium tuberculosis. Proc. Natl. Acad. Sci. USA 98, 7958-7963 (2001).
15. Held, K.S., Chen, B.P., Kuziel, W.A., Rollins, B.J. & Lane, T.E. Differential roles of CCL2 and CCR2 in host defense to coronavirus infection. Virology 329, 251-260 (2004).
16. Hokeness, K.L., Kuziel, W.A., Biron, C.A. & Salazar-Mother, T.P. Monocyte chemoattractant protein-1 and CCR2 interactions are required for IFN-α/β-induced inflammatory responses and antiviral defense in liver. J. Immunol. 174, 1549-1556 (2005).
17. + monocytes is essential for control of acute toxoplasmosis. J. Exp. Med. 201, 1761-1769 (2005).
18. -/- mice reveals a role for chemokines in the initiation of atherosclerosis. Nature 394, 894-897 (1998).
19. Izikson, L., Klein, R.S., Charo, I.F., Weiner, H.L. & Luster, A.D. Resistance to experimental autoimmune encephalomyelitis in mice lacking the CC chemokine receptor (CCR)2. J. Exp. Med. 192, 1075-1080 (2000).
20. Fife, B.T., Huffnagle, G.B., Kuziel, W.A. & Karpus, W.J. CC chemokine receptor 2 is critical for induction of experimental autoimmune encephalomyelitis. J. Exp. Med. 192, 899-905 (2000).
21. 2-integrin glycoprotein. Crit. Rev. Immunol. 20, 197-222 (2000).
22. Colonna, M., Trinchieri, G. & Liu, Y.J. Plasmacytoid dendritic cells in immunity. Nat. Immunol. 5, 1219-1226 (2004).
23. Lagasse, E. & Weissman, I.L. Flow cytometric identification of murine neutrophils and monocytes. J. Immunol. Methods 197, 139-150 (1996).
24. Serbina, N., Salazar-Mother, T.P., Biron, C., Kuziel, W.A. & Pamer, E.G. TNF/iNOS-producing dendritic cells mediate innate immune defense against bacterial infection. Immunity 19, 59-70 (2003).
25. Serbina, N.V. et al. Sequential MyD88-independent and -dependent activation of innate immune responses to intracellular bacterial infection. Immunity 19, 891-901 (2003).
26. Fleming, T.J., Fleming, M.L. & Malek, T.R. Selective expression of Ly-6G on myeloid lineage cells in mouse bone marrow. RB6-8C5 mAb to granulocyte-differentiation antigen (Gr-1) detects members of the Ly-6 family. J. Immunol. 151, 2399-2408 (1993).
27. - dendritic cells. Eur. J. Immunol. 31, 3403-3412 (2001).
28. Taylor, P.R., Brown, G.D., Geldhof, A.B., Martinez-Pomares, L. & Gordon, S. Pattern recognition receptors and differentiation antigens define murine myeloid cell heterogeneity ex vivo. Eur. J. Immunol. 33, 2090-2097 (2003).
29. Muraille, E. et al. Distinct in vivo dendritic cell activation by live versus killed Listeria monocytogenes. Eur. J. Immunol. 35, 1463-1471 (2005).
30. Ueda, Y., Yang, K., Foster, S.J., Kondo, M. & Kelsoe, G. Inflammation controls B lymphopoiesis by regulating chemokine CXCL12 expression. J. Exp. Med. 199, 47-58 (2004).
31. Nagaoka, H., Gonzalez-Aseguinolaza, G., Tsuji, M. & Nussenzweig, M.C. Immunization and infection change the number of recombination activating gene (RAG)-expressing B cells in the periphery by altering immature lymphocyte production. J. Exp. Med. 191, 2113-2120 (2000).
32. Rot, A. & von Andrian, U.H. Chemokines in innate and adaptive host defense: Basic chemokinese grammar for immune cells. Annu. Rev. Immunol. 22, 891-928 (2004).
33. Huo, Y. et al. The chemokine KC, but not monocyte chemoattractant protein-1, triggers monocyte arrest on early atherosclerotic endothelium. J. Clin. Invest. 108, 1307-1314 (2001).
34. Legler, D.F. et al. B cell-attracting chemokine 1, a human CXC chemokine expressed in lymphoid tissues, selectively attracts B lymphocytes via BLR1/CXCR5. J. Exp. Med. 187, 655-660 (1998).
35. Ansel, K.M. et al. A chemokine-driven positive feedback loop organizes lymphoid follicles. Nature 406, 309-314 (2000).
36. Reif, K. et al. Balanced responsiveness to chemoattractants from adjacent zones determines B-cell position. Nature 416, 94-99 (2002).
37. Hargreaves, D.C. et al. A coordinated change in chemokine responsiveness guides plasma cell movements. J. Exp. Med. 194, 45-56 (2001).
38. Dieu, M.C. et al. Selective recruitment of immature and mature dendritic cells by distinct chemokines expressed in different anatomic sites. J. Exp. Med. 188, 373-386 (1998).
39. Rollins, B.J. Chemokines. Blood 90, 909-928 (1997).
40. Yoshimura, T. et al. Purification and amino acid analysis of two human glioma-derived monocyte chemoattractants. J. Exp. Med. 169, 1449-1459 (1989).
41. Auerbuch, V., Brockstedt, D.G., Meyer-Morse, N., O'Riordan, M. & Portnoy, D.A. Mice lacking the type I interferon receptor are resistant to Listeria monocytogenes. J. Exp. Med. 200, 527-533 (2004).
42. Vallance, P. & Leiper, J. Blocking NO synthesis: How, where and why? Nat. Rev. Drug Discov. 1, 939-950 (2002).
43. Palladino, M.A., Bahjat, F.R., Theodorakis, E.A. & Moldawer, L.L. Anti-TNF-α therapies: The next generation. Nat. Rev. Drug Discov. 2, 736-746 (2003).
44. Deo, R. et al. Association among plasma levels of monocyte chemoattractant protein-1, traditional cardiovascular risk factors, and subclinical atherosclerosis. J. Am. Coll. Cardiol. 44, 1812-1818 (2004).
45. Gosling, J. et al. MCP-1 deficiency reduces susceptibility to atherosclerosis in mice that overexpress human apolipoprotein B. J. Clin. Invest. 103, 773-778 (1999).
46. Gu, L. et al. Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice. Mol. Cell 2, 275-281 (1998).
47. Takahashi, K. et al. Adiposity elevates plasma MCP-1 levels leading to the increased CD11b-positive monocytes in mice. J. Biol. Chem. 278, 46654-46660 (2003).
48. Charo, I.F. & Taubman, M.B. Chemokines in the pathogenesis of vascular disease. Circ. Res. 95, 858-866 (2004).
49. Kuziel, W.A. et al. Severe reduction in leukocyte adhesion and monocyte extravasation in mice deficient in CC chemokine receptor 2. Proc. Natl. Acad. Sci. USA 94, 12053-12058 (1997).
50. Lu, B. et al. Abnormalities in monocyte recruitment and cytokine expression in monocyte chemoattractant protein 1-deficient mice. J. Exp. Med. 187, 601-608 (1998).